000 01494 a2200445 4500
005 20250515115837.0
264 0 _c20080709
008 200807s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm8001444
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWard, Simon E
245 0 0 _aDiscovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMay 2008
300 _a2887-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBlood-Brain Barrier
_xmetabolism
650 0 4 _aCerebral Cortex
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aPiperazines
_xchemical synthesis
650 0 4 _aQuinolines
_xchemical synthesis
650 0 4 _aRadioligand Assay
650 0 4 _aRats
650 0 4 _aRecombinant Proteins
_xpharmacology
650 0 4 _aSerotonin 5-HT1 Receptor Antagonists
650 0 4 _aStructure-Activity Relationship
700 1 _aEddershaw, Peter J
700 1 _aScott, Claire M
700 1 _aGordon, Laurie J
700 1 _aLovell, Peter J
700 1 _aMoore, Susan H
700 1 _aSmith, Paul W
700 1 _aStarr, Kathryn R
700 1 _aThewlis, Kevin M
700 1 _aWatson, Jeannette M
773 0 _tJournal of medicinal chemistry
_gvol. 51
_gno. 10
_gp. 2887-90
856 4 0 _uhttps://doi.org/10.1021/jm8001444
_zAvailable from publisher's website
999 _c17930173
_d17930173